10 Einträge gefunden

1. Update Breast Cancer 2021 Part 1 - Prevention and Early Stages

   1. Stickeler, Elmar
   2. Aktas, Bahriye
   3. Behrens, Annika
   4. Belleville, Erik
   5. Ditsch, Nina
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Aktas, Bahriye
   4. Fasching, Peter A
   5. Hartkopf, Andreas
   6. Janni, Wolfgang
   7. Kasimir-Bauer, Sabine

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
3. Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Fehm, Tanja
   3. Janni, Wolfgang
   4. Aktas, Bahriye
   5. Fasching, Peter A
   6. Kasimir-Bauer, Sabine
   7. Milde-Langosch, Karin

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
4. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Pantel, Klaus
   5. Rack, Brigitte
   6. Janni, Wolfgang
   7. Fasching, Peter A

   2018 - Forschungsinformationssystem des UKE
5. Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Rack, Brigitte
   5. Janni, Wolfgang
   6. Fasching, Peter A
   7. Solomayer, Erich-Franz

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
6. Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Rack, Brigitte
   5. Janni, Wolfgang
   6. Fasching, Peter Andreas
   7. Solomayer, Erich-Franz

   2017 - Forschungsinformationssystem des UKE
7. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

   1. Aktas, Bahriye
   2. Kasimir-Bauer, Sabine
   3. Müller, Volkmar
   4. Janni, Wolfgang
   5. Fehm, Tanja
   6. Wallwiener, Diethelm
   7. Pantel, Klaus

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
8. Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.

   1. Müller, Volkmar
   2. Riethdorf, Sabine
   3. Rack, Brigitte
   4. Janni, Wolfgang
   5. Fasching, Peter A
   6. Solomayer, Erich
   7. Aktas, Bahriye

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
9. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.

   1. Müller, Volkmar
   2. Riethdorf, Sabine
   3. Rack, Brigitte
   4. Janni, Wolfgang
   5. Fasching, Peter A
   6. Solomayer, Erich
   7. Aktas, Bahriye

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
10. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

    1. Fehm, Tanja
    2. Müller, Volkmar
    3. Aktas, Bahriye
    4. Janni, Wolfgang
    5. Schneeweiss, Andreas
    6. Stickeler, Elmar
    7. Lattrich, Claus

    2010 - Forschungsinformationssystem des UKE